Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)
Operator of a biotechnology company intended to develop simulation-guided cell rejuvenation therapies to address the diseases of aging. Shift Bioscience is based in Cambridge, United Kingdom and was founded in 2017. Its last known valuation is $30.5 million. It has raised $17.5 million.
Last price · $/share
—
Implied valuation
$30.5M
Total raised
$17.5M
Last round
—
Cap table — not yet on record
Shift Bioscience's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Shift Bioscience with a free account
·The complete investor list: 13 names
·Watch Shift Bioscience: the Monday email on marks, rounds and moves
